ABSTRACT Ayurveda arrives to the portals of the contemporary legislation with soaring baggage of the history, custom and care of the human beings. It is more not the directory of plants and recipes as in dusty manuscripts, but a sort of an history, väids the treatment of patients in village courts, families concocting medication at home, laboratory experiments trying to isolate active properties to test them on patients: that indistinct reality is a key to asking the questions of law discussed in these parts: when the ancient recipe is the seed of a new substance that works around the world, who is the proprietor, who benefits, and shall active law go forth and put under restraint that sort of movement? This putting into doubt, in the paper, is achieved through an enquiry concerning the said questions through legal framework that has been founded on doctrines and how the statute with its books, its courts and its institutions have striven to remain abreast with the strain of commerce nor to contravene the communal rights here. The first portion of the analysis is the study of protection of doctrine provisions in the patent law in India. Winning; Organ 3(d) of the Patents Act is no technical rule-- it is a policy option which is as follows, the mere wrong pouching of known knowledge, is not a deserving monopoly .2 Novartis practice to that effect demonstrates the guardian angel; there must be, in addition to novelty, an actual, real progress to get a patent. Nonetheless, half a tale is the juridical escape of patenting; that evading prevents no compensation to the evil and provides no positive act to societies whose everyday understanding imparts the current-day innovation. It is in that gap that the biodiversity and ABS (access and benefit sharing) law comes in. The Biological Diversity Act and its recent amendments put prior-approval and benefit-sharing obligations at the centre of the regulatory map, indicating that access to biological resources and related knowledge was not a commercial issue to be a shrivelled-up-seller of without 7 That asymmetry is important since the defensive success stores of biopiracy such as invalidation of patents on turmeric or neem would be much more likely to be the subject of judicial than material effective decision-making.5 This asymmetry is important as the regulatory map, where benefit-sharing policies and the The example of not only promise but paradox is shown in the innovation within the policy of India, Traditional Knowledge Digital Library (TKDL). Meanwhile, translating practice Ayurvedically means making examinables at patent offices in other countries and, directly, prevents bad patents,7 Ayurvedic has made practices legible as datable entries, which are not necessarily expressed in formulaic entries by healers. Critics caution that writing itself poses the danger of paralyzing knowledge, which is, in any case, adaptive. The article therefore goes on to conclude on a diagnosis made on three observations. First, the Indian legal environment is not only potent on defensive protection doctrine but its TKDL also discourages appropriation. Second, it is less adequate on affirmative empowerment- ensuring that applications of its expertise in downstream are shared and they are economic to the owners. Third, there is a partial or incomplete state of institutional coherence, where laws, institutions, exist in the wrong state, there is no coherence and there is no local capacity. These are observed under the laws, and legal decisions, and departmental policy handouts and fine research. The article recommends a list of proposals of changes between diagnosis and prescription. What an alternative does give is a solution, although some of the measures identified by the proposed liberties on the practical law reform would certainly be an obligatory TK-disclosure and provenance requirement to patent applications (so that examiners and offices can know about any knowledgeable TK at very least), statutory clarifications on the calculation of deliquescent to be relinquished by administrative bodies, and continued interoperable interrelationship between TKDL and any overseas patent databases. These structural changes center on establishing the capacity development of the local committees, making the vaids get closer to the negotiation, and creating incentive schemes in which rewarding the collaborative and publishable research is compensated rather than the shrouded commercialization. And the final is that the paper is in favour of testing legal measures like Geographical Beings of geographically based formula and models of contracts which rely on such defaulting goals as co-ownership or revenue sharing in government-funded translational research. Nevertheless through a unity of these efforts, the reversible process of protection will be made an active mode and not a defensive mode: the law rules preventing misappropriation in conjunction with the communities being enabled to contribute in order to form, verify in addition to enjoying the fruits of new streams of information. This fact can cause a destabilization of Ayurveda as custodians are now placed as actors and not as providers so as to maintain both cultural and clinical vitality and also stereotype responsibility in innovation and welfare of the society. The paper concludes to state that Ayurveda heritage frozen is not the future of Ayurveda, marketing Ayurveda as an openly market is not the future of Ayurveda rather, legal regulations intended to appreciate the value of provenance, equity or success that Ayurveda can be scientifically investigated when given way. Keywords: Ayurveda; Traditional Knowledge; Intellectual Property Rights; Patent Law; Biodiversity Act; TKDL.
Snehasish Sarkar (Tue,) studied this question.